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Abstract
Glioblastoma is reported to be the most aggressive and common brain tumor in adults (Davis,
2016). To help alleviate pain in patients with glioblastoma, floatation-REST (Restricted
Environmental Stimulation Technique) is proposed. Such therapy has been shown to benefit
chronic tension headaches, muscle tension, and other stress-related pain conditions (Feinstein,
2018). The magnesium and sulfate components of Epsom salt combined with controlled warm
water allow the muscles and joints to relax. Studies show that magnesium targets the
Adrenocorticotropic Hormone (ACTH) produced by the Anterior Pituitary Gland which in turn
affects cortisol hormone levels to activate the body’s immune defenses and eliminate the cause
of pain and possible tissue recovery. This study aims to develop a conceptual framework that can
be used to determine the possible effect of floatation-REST on cortisol levels of patients with
glioblastoma for pain management.
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Introduction
Cancer has become increasingly prevalent in society today. The origins of the mutations
that lead to different cancers are caused by a variety of factors. Among these are environmental,
genetic, and lifestyle factors (Blackadar, 2016). Each factor can cause different types of cancers
such as lymphoma, lung cancer, breast cancer, melanoma, and much more (Siegal, 2020). To
counteract the high mutated disease, scientists with the help of advanced technology have come a
long way to finding and defeating cancer altogether (Siegal, 2020).
In an evaluation of cancer patients, the 5-year survival rate of patients in the United
States between 2009 and 2015 proved to be 67% overall across ethnicities, ages, genders, and
different types of cancers (Siegal, 2020). One particular cancer though has not been as prominent
to treatment as the others, is glioma. Glioma is a type of cancer that comes in many forms such
as astrocytoma and oligodendroglioma (Zong, 2012). These different types of glioma are created
by an overproduction of a particular glial cell. The overgrowth of oligodendrocytes, cells used to
create myelin for axons, creates a tumor called oligodendroglioma. On the other hand,
astrocytoma is caused by astrocytes which are cells used to do a variety of tasks. Some include
synaptic support and control of the blood-brain barrier. A sub-type of astrocytoma is
glioblastoma. Glioblastoma is the most common malignant brain tumor today (Thakkar et al.,
2014). As neural stem cells and multipotent progenitor cells generate lineage-restricted
progenitor cells that then create neurons and glial cells (astrocytes and oligodendrocytes), the
complexity of the cancerous origin is difficult to identify (Zong, 2012).
Presently, glioblastoma has had a low-survival rate as treatments to cure or resect the
cancer have not been successful (Davis, 2016). Despite many advancements in cancer treatment,
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the aggressiveness of glioblastoma, as well as the location of the tumor has made the survival
rate decrease in percentage (Davis, 2016). Therefore, it has come to attention that patients with
glioblastoma should be able to live a more fulfilled life with a decrease of pain and stress. Thus,
the issue at hand provides a list of questions that need to be answered:
1.

What therapies are currently used to alleviate pain or stress in general?

2.

Would floatation-REST be well suited for alleviating pain in patients with

glioblastoma?
3.

Do patients live longer if the immune system is not compromised by cancer

and pain/stress?
Many patients with glioblastoma do not live past five years of prognosis (Davis, 2016).
Thus, it is important to find a therapy that improves their quality of life while advancements in
technology are still being developed. Patients should not have to continuously rely on medication
to alleviate symptoms such as pain. Holistic therapies should be researched and considered as
alternatives to those medications.
Glioblastoma is an aggressive brain tumor that has had a low survival rate. The
overproduction of astrocytes in the central nervous system has caused treatment to be difficult, as
the nervous system is crucial to functions. Hence, a non-pharmacological modality is needed to
alleviate symptoms, such as pain and stress in patients with glioblastoma. Altogether, the hope is
to find an alternative pain management therapy for patients with glioblastoma in order to
improve their quality of life.
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Methodology
The following thesis is an extended literature review fabricated by a multitude of current
and historical peer reviewed articles discussing glioblastoma, current cancer treatments,
alternative pain therapies, and the systems of the human body. The information obtained was
used to discuss the pathology and characteristics of glioblastoma and provide alternative pain
therapies, specifically the utilization of floatation-REST therapy. Additional literature was
further gathered to design an experiment utilizing floatation-REST to test the current hypothesis
that cortisol levels of patients with glioblastoma grade IV will stabilize after being subjected to
the floatation-REST by the end of the experiment. Preliminary data gathering was incorporated
into the experimental design in order to recognize current treatments used by oncologists, and
their perception of alternative pain therapies, but more specifically, the utilization of floatationREST and the effects of magnesium in the treatment. The experiment was designed with
alterations to the testing parameters following the review of limited current studies that involve
floatation-REST. This information was collected primarily through databases such as PubMed
and PMC using key words such as ‘glioblastoma’, ‘floatation-REST’, ’sensory deprivation tank
therapy’, ‘the endocrine system’, and ‘magnesium sulfate’. Overall, this methodology functions
to inform the reader of the subject at hand with current treatments for patients with glioblastoma
grade IV, and viable alternative pain therapies such as the utilization of floatation-REST.
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Review of Literature
Glioblastoma is the most common and aggressive brain tumor known today. It has been
found that few patients live past five years of diagnosis as a result of its aggressiveness (Davis,
2016). Therefore, the science community is beginning to recognize that alternative therapies are
needed to counteract or alleviate some or all the symptoms these patients have (Carlsson, 2014).
Patients with glioblastoma have a diagnostic range of symptoms including, but not limited to the
following: headaches, muscle tension, muscle loss, and fatigue (Davis, 2016). Following the
analysis of a multitude of articles and sources, this literature review covers five general
categories: (1) what glioblastoma is and how it is currently treated, (2) different types of pain
that are associated with the body and cancer, (3) how cancer as a stimulus affects the endocrine
system that gradually affects the rest of the body, (4) various forms of non-pharmacological
therapies, (5) the effects of Floatation-REST (restricted environmental sensory therapy) on the
body from different studies using different types of patients, and (6) the effects of Epsom Salt
(magnesium sulfate) on the body and its various systems. It is critical to understand the
importance of each patient’s pain in order to aid them properly. Patients with glioblastoma
deserve to live their best quality of life, enjoying time with the people they love. Therefore,
decreasing a patient's pain through alternative therapy options is vitally important.
Glioblastoma: Overview and Current Treatments
Glioblastoma Multiforme (GBM) is a type of tumor located primarily in the brain.
Though it is commonly identified in the brain, it can also appear in the spinal cord by traveling
through the foramen magnum of the skull and down the posterior (Davis, 2016). Researchers
discovered that the complicated genetic profiling of GBM is established by a set of three core
signaling pathways that are commonly activated. These consist of the tumor protein p53
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pathway, the receptor tyrosine kinase/Ras/phosphoinositide 3-kinase signaling pathway, and the
retinoblastoma pathway. The use of these pathways allows the tumor cells to escape any cellcycle checkpoints (Davis, 2016). Despite a number of factors being associated with the cause of
cancer development, it is unknown how patients get glioblastoma.
The presentation of glioblastoma at diagnosis can vary depending on the size and location
of the tumor. Often, primary malignant glioblastomas occur mainly in adults, suggesting that the
cells being affected reside in a full-grown brain (Zong, 2012). In diagnostic imaging, necrosis
(dead cells) is the main feature of GBM that automatically makes the tumor a grade IV (Blissitt,
2014). When the tumor becomes grade IV, the survival rate diminishes to 12-15 months (Zong,
2012). Patients demonstrate symptoms of increased intracranial pressure, constant pain, and are
more likely to suffer a seizure due to the tumor (Davis, 2016). In addition to these symptoms, the
destruction of the brain cells often leads to a deficit in cognitive and emotional function (Zong,
2012). For example, the patient may feel exhausted or anxious as their emotional status is
altered. As the tumor encompasses parts of the brain, it is highly likely that the damage of
cortical and subcortical areas increases patient behavioral problems. Including the symptoms of
the tumor, cancer patients are unable to cope mentally with the thought of having cancer,
particularly patients with glioblastoma grade IV who have a definitively low survival rate. They
show signs of psychological distress and mood issues such as depression, anxiety, and suicidal
thoughts (Boele, 2015). It therefore is important to understand not only the symptoms, whether
there are direct effects of the tumor on the brain or a possible psychophysiological condition of
the patients.
Treatment of glioblastoma requires a multidisciplinary approach. Current treatment
includes maximal surgical resection, radiation, as well as the consumption of oral chemotherapy
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agent followed by chemotherapy (Davis, 2016). Surgical resection is classified as gross total
resection (GTR) and subtotal resection (STR) (Carlsson, 2014). In STR, the tumor is difficult to
undergo full resection, as the location of these tumors are around areas that are very important
for an individual to function. For instance, a tumor may display itself in the prefrontal cortex, the
anterior portion of the brain where critical thinking and personality takes place. If this area is
fully resected, the patient may have a personality change. As a result, surgery is not a promising
option for patients. An incomplete full resection thus leads to further progression of the tumor as
cells remain in the untouched areas. Through the progression of research, there has been an
advancement in surgical and preoperative mapping techniques to get better results throughout the
years. In the face of all the improvements in technology, it is difficult to determine the normal
brain from the tumor (Davis, 2016).
Additionally, another form of treatment following resection is chemoradiation. In this
stage of treatment, it has been determined that radiation therapy with TMZ chemotherapy is
more effective than radiation therapy alone (Davis, 2016). Although, TMZ is a risk due to this
type of chemotherapy potentially damaging the healthy cells in the location being targeted by the
radiation (Carlsson, 2014). Many patients will undergo chemoradiation in hopes that the tumor
will dissipate, yet despite the long use of treatment, GBM has found its way to resist and
progress (Fernandes, 2017).
Currently, there are ongoing clinical trials and research to improve the state of those that
are diagnosed with GBM (Carlsson, 2014). For example one treatment includes the use of
monoclonal antibodies. The antibodies recognize cell-surface receptors and ligands, hence
preventing receptor signaling. Furthermore, the secretion of vascular endothelial growth factor
(VEGF) by the GBM is blocked by the antibody being injected thus reducing the size of the
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tumor (Carlsson, 2014). Ultimately, based on current studies, more research should be done to
increase patient’s survival rate while also enhancing their quality of life.
Pain and Stress Caused by Cancer
Despite recent advances in comprehending cancer and developing the numerous ways to
treat varying types of tumors, the treatment of cancer pain has been slow in progression
(Chwistek, 2017). Pain can be produced in any form from body aches and sore muscles to pain
induced by cancer. In this case, glioblastoma grade IV comes with chronic headaches and muscle
tension in various areas of the body. Because GBM has a low survival rate, it should be
important to understand the pain that these patients live through in their daily struggles.
A factor that is manifested by pain or a stimulus is known as a stressor. A stressor is a
stimulus that triggers a physiological response often known as stress or anxiety. Those
physiological responses are threats to the safety and well-being of the body, which can be pain or
non-pain related (Hannibal, 2014). When a foreign stimulus is presented to the body, the
amygdala is triggered releasing hormones such as epinephrine and norepinephrine to destroy any
foreign invader. The prolonged response then triggers the endocrine system to respond back with
a series of regulated hormones, which maintain homeostasis within the body whether it is
controlling growth, development, or metabolism (Hiller-Sturmhöfel, 1998). Such functions are
produced by the endocrine glands, including the hypothalamus, the pituitary gland, the adrenal
glands, the thymus, the gonads, the pancreas, the parathyroid glands, and thyroid glands (Figure
1) (Hiller-Sturmhöfel, 1998).
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Figure 1. The location of the hormone- producing organs in the body (Maryniack, 2018).
To maintain homeostasis and obtain tight control, regulations of bodily functions are
achieved by the use of multiple hormones that regulate one another. The cascade of hormones is
initiated by the hypothalamus. From the hypothalamus, the releasing hormones are transported
via blood to their target glands which in turn influences multiple organs and systems. One
mechanism that controls this complex system is called the negative feedback loop. To ensure that
there is not an excess of one hormone in the body, the negative feedback loop shuts off the
hypothalamic or pituitary hormone release (Hiller-Sturmhöfel, 1998).
The three main glands under focus in this research are the hypothalamus, pituitary, and
adrenal glands. The hypothalamus is a region of the brain that controls many functions such as
eating and drinking, circadian rhythm, emotional states, blood pressure, and much more. As a
result of the hypothalamus being part of the central nervous system, it serves as a bridge between
the nervous and endocrine system. For example, the hypothalamus will respond when the brain
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transmits a nerve impulse affecting external or internal factors that disrupt homeostasis by
releasing a series of hormones relative to the function necessary for homeostasis regulation. The
gland that receives these hormones is known as the pituitary gland. The pituitary gland is divided
into two parts: the anterior pituitary and the posterior pituitary. The anterior pituitary produces
hormones such as adrenocorticotropic hormone (ACTH), gonadotropins, thyroid-stimulating
hormone, growth hormone, and prolactin. The posterior pituitary stores two hormones that
include vasopressin and oxytocin that are produced by the hypothalamus (Hiller-Sturmhöfel,
1998). In need of these hormones, the adrenal gland receives them via a release into the
bloodstream in order to reach their target. For example, the adrenal gland releases cortisol to
provide a multitude of functions (figure 2) (Hannibal, 2014). Cortisol levels then rise to provide
energy to cope with a stress-related stimulus or escape any danger-related situation. If the
stimulus is prolonged, cortisol levels will plummet, as the hypothalamic-pituitary-adrenal (HPA)
axis ceases to function properly. Through the application of these physiological functions,
specifically to patients with glioblastoma, it can be inferred that levels of cortisol will fluctuate
as pain can be either chronic or acute.

Figure 2: The Negative Feedback Loop of Cortisol Release (Konkel, 2018).
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Stress can have a wide variety of effects stretching from brain function to various systems
being affected. While analyzing articles about stress, Yaribeygi (2017) found that there is a direct
correlation between stress and the body’s immune system. The physiological response that the
body encounters can lead to an inhibition of the immune system by decreasing the activity of
cytotoxic T-lymphocytes and natural killer cells. Therefore, malignant cells such as cancer cells
are able to expand with ease (Reiche et al., 2004). Other diseases that have been linked to stress
include mental illnesses such as depression and anxiety disorders. When a person is in a state of
chronic stress, the neuroimmune axis can be overstimulated causing neuroendocrine/immune
imbalances leading to such mental illnesses and more (Mariotti, 2015).
To counteract the symptoms of pain, anxiety, and mood disturbances, there are
complementary therapies that are able to help. Such therapies include acupuncture, massage, and
other methods. The utilization of massage therapy has demonstrated a slow relief of pain in most
patients. Similar to massage, acupuncture through studies has shown promise for pain relief
benefits. It has been shown to reduce chronic and acute pain (Deng, 2009). Another form of
therapy that has been used to alleviate symptoms of physical and emotional pain is mind-body
techniques. This therapy has been found to alter the perception of pain or emotional disturbances
(Deng, 2009). Hypnosis and imagery training can reduce the use of analgesic use thus reducing
side effects of analgesics. While these therapies have shown to help many patients in studies,
there are limitations to all of these therapies. For this reason, floatation-REST (restricted
environmental sensory therapy) should be considered as an option as well. This type of therapy
can reach patients that would not otherwise be reached by the therapies available now.
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Floatation-REST as an alternative therapy
Floatation-REST is a type of therapy that involves an enclosed tank which can be easily
opened and closed from the inside as seen in figure 3 (Bood, 2009). The individual enters into
the tank filled with a minimum amount of water saturated with a high concentration of Epsom
salt (magnesium sulfate) (Feinstein, 2018). Because Epsom salt concentrate increases the density
of the water, a high salt concentration produces a high enough density giving individuals the
ability to float effortlessly. The tank is built to prevent any heat from escaping, as well as any
sound or light to enter in order to minimize sensory input (Bood, 2009). This type of therapy has
been circulating for more than 50 years, but it has not become popular until recently due to the
increased availability of pools and spacious tanks (Feinstein, 2018).

Figure 3: A floatation-REST tank with an optional closed hatch in an enclosed room (Ashland
Source, 2020).
As a result of limited studies utilizing isolation tank therapy specifically on patients with
glioblastoma, research studying these patients with similar symptoms were analyzed. Initially, a
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study by Feinstein and his colleagues (2018) determined the effects of floatation-REST on
symptoms of anxiety, stress, and depression. Within this study, seventeen patients were selected
at random across a variety of anxiety and stress-related disorders. As a point of reference, thirty
healthy and non-anxious patients were also selected at random to participate. In the study, the
self-reported measurements the authors administered included baseline measures, pre/post-float
measures, and follow-up questions. These measurements ensured there was sufficient data to
cover all possible questions encompassing the concept of floatation-REST as a possible therapy.
Each group participated in the open float pool created by the Laureate Institute for Brain
Research to exclude any feelings of claustrophobia. Altogether, the seventeen patients with
disorders reported to have a significant reduction in stress, depression, and pain while also
improving their mood. Following the completion of the study, it was concluded that the effects
of the floatation-REST were greatest concerning the most severely anxious participants
(Feinstein, 2018). The results of this article positively display the effects of the floatation-REST
on symptoms that negatively affect an individual.
Jonsson and Kjellgren (2016) assessed general anxiety disorder (GAD) symptoms before
and after the use of floatation-REST therapy. The patients were placed into two groups: a control
group and a treatment group. Prior to treatment, questionnaires provided a multitude of
measurements such as worry, general anxiety disorder, depression rating, sleep quality,
emotional regulation, mindful attention awareness, and the experienced deviation from normal
state. The study lasted twelve weeks where the patients were able to float in an isolated tank of
water with concentrated Epsom salt. The results demonstrated a positive correlation between the
symptoms of the treatment group and the treatment itself. Most of the measurements under
analysis decreased in intensity after the use of the treatment tanks, hence providing more support
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in the utilization of the restricted environmental sensory tanks as a form of therapy for patients
with glioblastoma who may experience similar symptoms. The authors also found it interesting
that floatation-REST significantly improved GAD symptoms despite the fact that GAD was
considered a treatment-resistant disorder (Jonsson, 2016). Overall, this article reinforced the
topic at hand regarding the potential positive effects of utilizing flotation-REST therapy in the
treatment of the patients experiencing glioblastoma.
Finally, the article by Kjellgren and Westman (2014) evaluated the effects of healthy
individuals who participated in floatation-REST. The study randomized sixty-five participants
from different business companies into a control group and treatment group. Similar to the
previous studies, the participants were given questionnaires measuring psychological and
physiological variables before and after the treatments. The study lasted a total of twelve
sessions where each session lasted forty-five minutes. At the conclusion of the study, symptoms
such as stress, anxiety, depression, and worsened pain decreased while optimism and sleep
quality increased within the treatment group. On the contrary, the control group did not show a
difference in the observed psychological and physiological measurements after the treatment
(Kjellgren, 2014). Thus, this article has proven that those individuals who do not suffer from an
illness or a disorder may also benefit from floatation-REST and its positive properties.
All three articles have had similar results in alleviating the patient’s conditions, such as a
decrease in pain, stress, anxiety, and depression. By utilizing the body-temperature, water, and
Epsom salt properties, the muscles relax and all functions of the organ systems return to normal.
Body systems such as the endocrine system that were being overused are able to regulate
themselves by using negative feedback loop, thus allowing the body to live in homeostasis. For
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example, the cortisol levels that deal with stress and pain when normalized could result in a
decrease in the levels of stress and pain.
Epsom Salt
Epsom salt also known as magnesium sulfate is the main component used in floatationREST therapy. The high concentration of the salt is what allows individuals to float in the water
effortlessly by adding mass to the water without additional volume. In practice, with the addition
of water, the Epsom salt dissociates into magnesium and sulfate ions which are able to permeate
through the tough layer of skin known as the stratum corneum (Elbossaty, 2018). In a study
conducted by Navin Chandrakanth Chandrarasekaran et. al. (2016), magnesium was found to
permeate through human skin when applied topically. Before the experiment, the authors
postulated that the magnesium ions could potentially move through the pores or the hair follicles
through bulk diffusion. The hypothesis was investigated in a number of ways. The authors
obtained excised human skin from patients that underwent abdominoplasty. For the first
experiment, they applied deionised water and 5 mM MgCl₂ solution for 30 minutes at 23-25 ℃
using the upper chamber of a franz cell (Navin Chandrakanth Chandrarasekaran et. al., 2016).
Using a Zeiss Primostar microscope and Zeiss AxioCam Erc 5s, the group conducted another
experiment to see if MgCl₂ permeated through hair follicles by plugging the hair follicles with
acriflavine solution. Lastly, they experimented with 52 mM and 1.9 M MgCl₂ solutions for 5, 15,
and 60 minutes to investigate the effects of concentration and time on the permeation of
magnesium. From the experimental results using skin, MgCl₂, and indirect staining of
magnesium ions, the authors concluded that magnesium is capable of permeating through the
epidermis, especially at a faster rate when the hair follicle orifices are open. They also observed a
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greater influx of magnesium ions within the body when the authors applied an increased
concentration of MgCl₂ on the skin for 60 minutes.
Another study, “Permeability of Human Skin to Selected Anions, and Cations - In Vitro
Studies'' by Halina Laudańska el. at. (2002) also examined ion diffusion through the human skin.
By using an in-vitro system, the authors were able to evaluate Mg²⁺, Ca²⁺, NO₃⁻, and SO₄²⁻. They
used skin samples from mammectomized breasts of 27 breast cancer patients that were frozen
until utilized. The skin samples were placed in the in-vitro system where an ion chromatography
method was used to determine cation and anion levels. Laudańska el. at. (2002) concluded from
multiple experiments that magnesium, calcium, sulfate, and nitrate ions are able to permeate
through the human skin via various routes of ion penetration.
There are a variety of benefits of Epsom salt. Some of the medical benefits include: body
relaxation, pain and muscle relief, improvement of muscle and nerve function, and detoxification
effects. Magnesium has been found to be a cofactor in over 300 enzymatic reactions (Gröber,
2015). Some of those reactions are microscopic; however other reactions such as the regulation
of muscle contractions and blood pressure provide a much greater reaction (Gröber, 2015). In
regards to body relaxation, the magnesium ions control the influx of calcium at the cell
membrane while also producing serotonin, a neurotransmitter in charge of positive satisfaction
(Grober, 2015). The regulation of calcium through the inhibition of influx can be seen in figure
4.
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Figure 4: The magnesium ion blocks calcium from entering the cell thus preventing
muscle contraction (Lopez, 2012).
Magnesium not only plays a role in body relaxation, it also inhibits nerve receptors
linked to the area of pain and regulates the release of neurohormones in order to relieve pain or
muscle tension. To improve the function of nerves and muscles, inflammatory responses such as
a release of pro-inflammatory proteins decrease due to the cellular magnesium increasing in the
body. Lastly, the sulfate ions in Epsom salt are used to help the body pump heavy metals and
toxins out. In order for the body to be able to perform the task, cells need energy (ATP) to be
able to pump out the toxins. As a result, Magnesium assists in the generation of energy in the
cells (ATP) (Elbossaty, 2018). Therefore, the individual is able to de-stress, relax, and feel
energized after a session in the flotation-REST therapy.
Magnesium is a very important factor that can affect the body greatly, such as affecting
cortisol and the hypothalamic-pituitary-adrenal axis. One study by Sartori (2012) assessed how
important magnesium deficiency was on the HPA axis. Through research by Sartori, it has been
found that magnesium controls the productivity of the HPA axis (Murck and Steiger, 1998). This
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raised the question regarding the correlation between the two variables. They split mice into two
groups: a control and an experimental. The experimental group received a magnesium deficient
diet as well as either desipramine or paroxetine via drinking water while the control group
received a normal magnesium-based diet. At the end of the 12-week study, the results displayed
the magnesium deficient mice having an increase in the ACTH hormone as compared to the
control group. This outcome is due to the increase of transcription of the prepo-CRH in the
paraventricular hypothalamic nucleus (PVN) (Sartori, 2012). Furthermore, the increase of the
ACTH hormone proves that magnesium does play a role in the activity of the HPA axis thus
demonstrating that magnesium can inhibit the overall production of cortisol.
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Proposal
The objective of this proposed study is to investigate the effects of floatation-REST on
cortisol levels in patients with glioblastoma grade IV. Floatation-REST has been shown in the
previous studies to have beneficial effects on the human body. Such treatment has been shown to
benefit chronic tension headaches, muscle tension, and other stress-related pain conditions.
Based on the results of these studies and the research gathered, it is hypothesized that the patients
using floatation-REST with Epsom salt will have a stabilization in cortisol levels and decreased
pain than the control group.
Experimental Design
Preliminary research
Data will consist of analyzed online surveys from licensed oncologists in order to gather
medically-based information regarding their professional opinions on alternative pain therapy,
specifically floatation-REST. Thirty Florida licensed oncologists will be selected via a
convenient sampling, non-experimental design with the assistance of a local hospital. A
PowerPoint detailing floatation-Rest research will be provided as the study intervention. This
intervention will demonstrate the potential effectiveness of floatation REST as a pain
management treatment alternative for patients with glioblastoma grade IV. The PowerPoint will
also provide specific details regarding the connection between magnesium sulfate utilized in
floatation-REST and the inhibition of pain. Cortisol will also be highlighted as a biomarker,
indicating that the magnesium sulfate in floatation-REST was effective at reducing pain. The
data for this study will be collected from a combination of survey and interview questions via
Qualtrics. All oncologists will receive a mix-methods questionnaire that contains seven questions
and an informative PowerPoint via email. Of those seven questions, four questions are survey
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questions that include the use of the Likert scale. In order to obtain concrete data and see patterns
within the results, all participants will receive the same questions and PowerPoint that can be
observed in Appendices A and B. The results of the survey will help the researchers determine
which oncologists will be interested in co-investigating this study, as well as aid in the
recruitment of patients with glioblastoma grade IV.
Participants
Inclusion criteria include patients with glioblastoma grade IV between the ages of 30 - 48
with their physician’s approval from various hospitals in Florida. Fifty participants will be
recruited to volunteer using resources from the affiliated oncologists on the research team. These
participants will be randomly assigned between the experimental and control groups. The former
will consist of 25 participants receiving floatation-REST with Epsom salt and the latter will
consist of 25 participants using floatation-REST without Epsom salt.
Measures
Each patient will have their plasma cortisol levels measured and pain evaluated using the
Brief Pain Inventory scale before and after floatation-REST for 60 minutes. The plasma cortisol
levels will serve as a biomarker to indicate whether the physiological response to pain has
reduced after the utilization of floatation-REST thus giving unbiased results. Each test will be
administered at a local Labcorp. As for the Brief Pain Inventory scale, it is a self-administered
questionnaire that identifies pain intensity and pain interference as seen in figure 5 (Poquet et.
al., 2016). The questionnaire will serve as a second metric that will help determine whether
floatation-REST is effective at reducing pain.
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Figure 5: The following Brief Pain Inventory Scale short form questionnaire is given to
the patients to assess their pain intensity and pain interference. There are a total of nine
questions with subsections within question nine (The University of Texas MD Anderson Cancer
Center, 2022).
Floatation tanks
The parameters of this study are built on prior research established by the multiple studies
evaluated in the literature review. In this study, the floatation tank will be 8 ft. long and 4.5 ft.
wide. One tank will be filled with 10 inches of water saturated with Epsom salt (magnesium
sulfate), while another tank will be filled with water and no Epsom salt. The water temperature
will be held at a constant temperature of 35 ℃. The tanks will be held in quiet rooms in order to
block out any sound or disturbances. When participants enter the tank, participants are
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encouraged to close the hatches of the tank. Latches are available inside the tank if participants
would like to exit the tank. A blue LED light will also be available to participants if they need it,
but they are encouraged to leave the lights off.
Procedure
The experiment will take place between 1 PM and 5 PM. Before entering the tanks, each
patient will have their blood drawn to test cortisol levels and fill out a brief pain inventory scale
form. Patients will be randomly assigned to the experimental group and control group evenly. The
experimental group will consist of a tank with Epsom salt. The control group will consist of a tank
with no Epsom salt. Following 60 minutes, each patient will exit the tank and plasma cortisol levels
will be obtained via blood draw and recorded. Patients will end their session by filling out a brief
pain inventory scale form. This study will be done 3x a week for 4 weeks and the data will be
statistically analyzed using SAS software.
Future Implications
Due to limited studies, there are many unanswered questions. Though the studies proved
to show a positive correlation between the utilization of floatation-REST and a reduction in
negative symptoms similar to patients with glioblastoma, there were no studies done regarding
the therapy and patients with glioblastoma. For that reason, a study has been proposed to close
the gap in research. Once the proposed study is completed, there are a few different implications
that could arise. These implications could include expanding the participant pool to further
analyze the effectiveness of floatation-REST. Future research should assess different times a
person floats, as this could affect their cortisol levels. Lastly, various concentrations of Epsom
salt can be evaluated to determine the effectiveness of this therapy.
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Conclusion
Despite initial maximal resection and multimodal therapies, less than 5% of patients with
glioblastoma survive five years after prognosis (Davis, 2016). Patients cope with symptoms
including headaches, muscle loss, depression, pain, and mood changes (Davis, 2016). These
symptoms may result from a variety of causes, such as the cancer, pharmacological therapies, or
the medication prescribed to alleviate the initial symptoms. Therefore, it has come to my
attention to find an alternative non-pharmacological pain management that can give patients with
glioblastoma a more fulfilled life with a decrease of pain and stress.
Currently, there are non-pharmacological therapies that have shown to help cancer
patients in alleviating pain. Because these therapies have been proven to have limitations,
floatation-REST should be considered as a viable option. By using this modality, patients who
would otherwise avoid current therapies are able to receive the assistance they need. Due to
limited public exposure on floatation-REST, there have been no studies dedicated to see its effect
on patients with glioblastoma. For this reason, this extended literature review proposes a
conceptual framework for a future study to determine the effectiveness of floatation-REST on
cortisol levels of patients with glioblastoma grade IV. This study will then evaluate the current
hypothesis; patients with glioblastoma grade IV in the experimental group that includes
floatation-REST and Epsom salt will have a normal range of cortisol levels as compared to the
control group. If this proposal were to be conducted and show similar results to previous studies,
this non-pharmacological pain therapy can be utilized as an option for pain management.
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